Synthetic Strategies for Engineering Intravenous Hemostats

Bioconjugate Chemistry

Volumn 26, Issue 7, 2015, Pages 1224-1236

  Chan, Leslie W ^a   White, Nathan J ^b   Pun, Suzie H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; LIPOSOMES; PARTICLE SIZE; TARGETED DRUG DELIVERY;

'CURRENT; BLEEDINGS; BLOOD LOSS; CLINICAL METHODS; HAEMOSTASIS; HEMOSTATIC AGENTS; LARGE VOLUMES; SHELF LIFE; SYNTHETIC STRATEGIES; VASCULAR INJURY;

PLATELETS;

HEMOSTATIC AGENT; LIPOSOME; NANOPARTICLE; FIBRIN; PEPTIDE;

ARTICLE; BLOOD CLOTTING; BLOOD VESSEL INJURY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FIBRIN FORMATION; HEMOSTASIS; HUMAN; NONHUMAN; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; RECEPTOR DENSITY; THROMBOCYTE; AMINO ACID SEQUENCE; ANIMAL; ARTIFICIAL CELL; CHEMISTRY; CYTOLOGY; DRUG DEVELOPMENT; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MOLECULAR GENETICS; PROCEDURES;

ADMINISTRATION, INTRAVENOUS; AMINO ACID SEQUENCE; ANIMALS; ARTIFICIAL CELLS; BLOOD PLATELETS; DRUG DISCOVERY; FIBRIN; HEMOSTASIS; HEMOSTATICS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 84937061150     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00070     Document Type: Article

References (93)

1. Kauvar, D. S., Lefering, R., and Wade, C. E. (2006) Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations J. Trauma 60, S3-11
2. Eastridge, B. J., Mabry, R. L., Seguin, P., Cantrell, J., Tops, T., Uribe, P., Mallett, O., Zubko, T., Oetjen-Gerdes, L., and Rasmussen, T. E. 2012, Death on the battlefield (2001-2011): implications for the future of combat casualty care J. Trauma Acute Care Surg. 73, S431-7
3. Achneck, H. E., Sileshi, B., Jamiolkowski, R. M., Albala, D. M., Shapiro, M. L., and Lawson, J. H. (2010) A comprehensive review of topical hemostatic agents: efficacy and recommendations for use Ann. Surg 251, 217-228
4. Spahn, D. R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernandez-Mondejar, E., Filipescu, D., Hunt, B. J., Komadina, R., and Nardi, G. 2013, Management of bleeding and coagulopathy following major trauma: an updated European guideline Crit. Care 17, R76
5. Takeoka, S., Teramura, Y., Okamura, Y., Tsuchida, E., Handa, M., and Ikeda, Y. (2002) Rolling properties of rGPIbα-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions Biochem. Biophys. Res. Commun. 296, 765-770
6. Pease, D. C. (1956) An electron microscope study of red bone marrow Blood 11, 501-526
7. Machlus, K. R. and Italiano, J. E., Jr. (2013) The incredible journey: From megakaryocyte development to platelet formation J. Cell Biol. 201, 785-796
8. Gentile, F., Chiappini, C., Fine, D., Bhavane, R. C., Peluccio, M. S., Cheng, M. M. C., Liu, X., Ferrari, M., and Decuzzi, P. (2008) The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows J. Biomech. 41, 2312-2318
9. Nishiya, T., Kainoh, M., Murata, M., Handa, M., and Ikeda, Y. (2002) Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions Blood 100, 136-142
10. Chen, H., Locke, D., Liu, Y., Liu, C., and Kahn, M. L. (2002) The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion J. Biol. Chem. 277, 3011-3019
11. Pytela, R., Pierschbacher, M. D., Ginsberg, M. H., Plow, E. F., and Ruoslahti, E. (1986) Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors Science (Washington, DC, U. S.). 231, 1559-1562
12. Plow, E. F. and Ginsberg, M. H. (1989) Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor Prog. Hemost. Thromb. 9, 117-156
13. Salsmann, A., Schaffner-Reckinger, E., Kabile, F., Plancon, S., and Kieffer, N. (2005) A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin αIIβ3-dependent RhoA activation during cell spreading J. Biol. Chem. 280, 33610-33619
14. Modery-Pawlowski, C. L., Tian, L. L., Pan, V., McCrae, K. R., Mitragotri, S., and Sen Gupta, A. (2013) Approaches to synthetic platelet analogs Biomaterials 34, 526-541
15. Wagner, C. L., Mascelli, M. A., Neblock, D. S., Weisman, H. F., Coller, B. S., and Jordan, R. E. (1996) Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets Blood 88, 907-914
16. Bennett, J. S. and Vilaire, G. (1979) Exposure of platelet fibrinogen receptors by ADP and epinephrine J. Clin. Invest. 64, 1393-1401
17. Marguerie, G. A., Edgington, T. S., and Plow, E. F. (1980) Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation J. Biol. Chem. 255, 154-161
18. Niiya, K., Hodson, E., Bader, R., Byers-Ward, V., Koziol, J. A., Plow, E. F., and Ruggeri, Z. M. (1987) Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation Blood 70, 475-483
19. Agam, G. and Livne, A. (1983) Passive participation of fixed platelets in aggregation facilitated by covalently bound fibrinogen Blood 61, 186-191
20. Agam, G. and Livne, A. A. (1992) Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia Eur. J. Clin. Invest. 22, 105-112
21. Coller, B. S., Springer, K. T., Beer, J. H., Mohandas, N., Scudder, L. E., Norton, K. J., and West, S. M. (1992) Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions J. Clin. Invest. 89, 546-555
22. Levi, M., Friederich, P. W., Middleton, S., de Groot, P. G., Wu, Y. P., Harris, R., Biemond, B. J., Heijnen, H. F., Levin, J., and ten Cate, J. W. (1999) Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits Nat. Med. 5, 107-111
23. Davies, A. R., Judge, H. M., May, J. A., Glenn, J. R., and Heptinstall, S. (2002) Interactions of platelets with Synthocytes, a novel platelet substitute Platelets 13, 197-205
24. Allen, T. M. and Cullis, P. R. (2013) Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Delivery Rev. 65, 36-48
25. Sie, P., Gillois, M., Boneu, B., Chap, H., Bierme, R., and Douste-Blazy, L. (1980) Reconstitution of liposomes bearing platelet receptors for human von Willebrand factor Biochem. Biophys. Res. Commun. 97, 133-138
26. Baldassare, J. J., Kahn, R. A., Knipp, M. A., and Newman, P. J. (1985) Reconstruction of platelet proteins into phospholipid vesicles. Functional proteoliposomes J. Clin. Invest. 75, 35-39
27. Parise, L. V. and Phillips, D. R. (1985) Platelet membrane glycoprotein IIb-IIIa complex incorporated into phospholipid vesicles. Preparation and morphology J. Biol. Chem. 260, 1750-1756
28. Rybak, M. E. (1989) A platelet substitute-the plateletsome to be used in transfusion therapy, pp 1-41, US Army Medical Research and Development Command, Fort Detrick, Frederick, MD.
29. Rybak, M. E. and Renzulli, L. A. (1993) A liposome based platelet substitute, the plateletsome, with hemostatic efficacy Biomater. Artif. Cells Immobil. Biotechnol. 21, 101-118
30. Kitaguchi, T., Murata, M., Iijima, K., Kamide, K., Imagawa, T., and Ikeda, Y. (1999) Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibα: a potential substitute for platelet transfusion Biochem. Biophys. Res. Commun. 261, 784-789
31. Nishiya, T., Kainoh, M., Murata, M., Handa, M., and Ikeda, Y. (2001) Platelet interactions with liposomes carrying recombinant platelet membrane glycoproteins or fibrinogen: approach to platelet substitutes Artif. Cells Blood Substit. Immob. Biotechnol. 29, 453-464
32. Okamura, Y., Maekawa, I., Teramura, Y., Maruyama, H., Handa, M., Ikeda, Y., and Takeoka, S. (2005) Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo Bioconjugate Chem. 16, 1589-1596
33. Okamura, Y., Takeoka, S., Teramura, Y., Maruyama, H., Tsuchida, E., Handa, M., and Ikeda, Y. (2005) Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo Transfusion 45, 1221-1228
34. Okamura, Y., Fujie, T., Maruyama, H., Handa, M., Ikeda, Y., and Takeoka, S. (2007) Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide Transfusion 47, 1254-1262
35. Okamura, Y., Fujie, T., Nogawa, M., Maruyama, H., Handa, M., Ikeda, Y., and Takeoka, S. (2008) Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits Transfus. Med. 18, 158-166
36. Modery, C. L., Ravikumar, M., Wong, T. L., Dzuricky, M. J., Durongkaveroj, N., and Sen Gupta, A. (2011) Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery Biomaterials 32, 9504-9514
37. Ravikumar, M., Modery, C. L., Wong, T. L., Dzuricky, M., and Sen Gupta, A. P. D. (2012) Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes Bioconjugate Chem. 23, 1266-1275
38. Ravikumar, M., Modery, C. L., Wong, T. L., and Gupta, A. S. (2012) Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro Biomacromolecules 13, 1495-1502
39. Modery-Pawlowski, C. L., Tian, L. L., Ravikumar, M., Wong, T. L., and Sen Gupta, A. (2013) In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct Biomaterials 34, 3031-3041
40. Okamura, Y., Takeoka, S., Eto, K., Maekawa, I., Fujie, T., Maruyama, H., Ikeda, Y., and Handa, M. (2009) Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute J. Thromb. Haemost. 7, 470-477
41. Bertram, J. P., Williams, C. A., Robinson, R., Segal, S. S., Flynn, N. T., and Lavik, E. B. (2009) Intravenous hemostat: nanotechnology to halt bleeding Sci. Transl. Med. 1, 11ra22
42. Hans, M. L. and A. M. L (2002) Biodegradable nanoparticles for drug delivery and targeting Curr. Opin. Solid State Mater. Sci. 6, 319
43. Shoffstall, A. J., Atkins, K. T., Groynom, R. E., Varley, M. E., Everhart, L. M., Lashof-Sullivan, M. M., Martyn-Dow, B., Butler, R. S., Ustin, J. S., and Lavik, E. B. (2012) Intravenous hemostatic nanoparticles increase survival following blunt trauma injury Biomacromolecules 13, 3850-3857
44. Doshi, N., Prabhakarpandian, B., Rea-Ramsey, A., Pant, K., Sundaram, S., and Mitragotri, S. (2010) Flow and adhesion of drug carriers in blood vessels depend on their shape: A study using model synthetic microvascular networks J. Controlled Release 146, 196-200
45. Anselmo, A. C., Modery-Pawlowski, C. L., Menegatti, S., Kumar, S., Vogus, D. R., Tian, L. L., Chen, M., Squires, T. M., Sen Gupta, A., and Mitragotri, S. (2014) Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries ACS Nano 8, 11243-53
46. Charoenphol, P., Huang, R. B., and Eniola-Adefeso, O. (2010) Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers Biomaterials 31, 1392-402
47. Muller, K., Fedosov, D. A., and Gompper, G. (2014) Margination of micro- and nano-particles in blood flow and its effect on drug delivery Sci. Rep. 4, 4871
48. Müller, K., Fedosov, D. A, and Gompper, G. (2014) Margination of micro- and nano-particles in blood flow and its effect on drug delivery Sci. Rep. 4, 4871
49. Decuzzi, P., Pasqualini, R., Arap, W., and Ferrari, M. (2009) Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res. 26, 235-43
50. Jones, S. W., Roberts, R. A., Robbins, G. R., Perry, J. L., Kai, M. P., Chen, K., Bo, T., Napier, M. E., Ting, J. P., and Desimone, J. M. 2013, Nanoparticle clearance is governed by Th1/Th2 immunity and strain background J. Clin. Invest. 123, 3061-3073
51. Champion, J. a and Mitragotri, S. (2006) Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U. S. A. 103, 4930-4
52. Swaroop, M., Straus, D. C., Agubuzu, O., Esposito, T. J., Schermer, C. R., and Crandall, M. L. (2013) Pre-hospital transport times and survival for Hypotensive patients with penetrating thoracic trauma J. Emerg. Trauma Shock 6, 16-20
53. Champion, J. a and Mitragotri, S. (2009) Shape induced inhibition of phagocytosis of polymer particles Pharm. Res. 26, 244-9
54. Arnida, Janát-Armsbury, M. M., Ray, A., Peterson, C. M., and Ghandehari, H. (2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages Eur. J. Pharm. Biopharm. 77, 417-23
55. Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., and Discher, D. E. (2007) Shape effects of filaments versus spherical particles in flow and drug delivery Nat. Nanotechnol. 2, 249-255
56. Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., and McNeil, S. E. (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol. Pharmaceutics 5, 487-495
57. He, C., Hu, Y., Yin, L., Tang, C., and Yin, C. (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31, 3657-66
58. Bennett, J. S., Berger, B. W., and Billings, P. C. (2009) The structure and function of platelet integrins J. Thromb. Haemost. 7 (Suppl 1) 200-205
59. Cheresh, D. A. (1987) Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor Proc. Natl. Acad. Sci. U. S. A. 84, 6471-6475
60. Pierschbacher, M. D. and Ruoslahti, E. (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule Nature 309, 30-33
61. Pierschbacher, M. D. and Ruoslahti, E. (1987) Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion J. Biol. Chem. 262, 17294-17298
62. Cheng, S., Craig, W. S., Mullen, D., Tschopp, J. F., Dixon, D., and Pierschbacher, M. D. (1994) Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin α IIb β 3 antagonists J. Med. Chem. 37, 1-8
63. Srinivasan, R., Marchant, R. E., and Gupta, A. S. (2009) In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes J. Biomed Mater. Res., Part A 93, 1004-1015
64. Beer, J. H., Springer, K. T., and Coller, B. S. (1992) Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor Blood 79, 117-128
65. Gu, F., Zhang, L., Teply, B. a, Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., and Farokhzad, O. C. (2008) Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc. Natl. Acad. Sci. U. S. A. 105, 2586-91
66. Garg, A., Tisdale, A. W., Haidari, E., and Kokkoli, E. (2009) Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide Int. J. Pharm. 366, 201-10
67. Gindy, M. E., Ji, S., Hoye, T. R., Panagiotopoulos, A. Z., and Prudhomme, R. K. (2008) Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density Biomacromolecules 9, 2705-11
68. Olivier, V., Meisen, I., Meckelein, B., Hirst, T. R., Peter-Katalinic, J., Schmidt, M. A., and Frey, A. (2003) Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems Bioconjugate Chem. 14, 1203-8
69. Roche, A. M., James, M. F., Bennett-Guerrero, E., and Mythen, M. G. (2006) A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids Anesth. Analg. 102, 1274-1279
70. Elias, D. R., Poloukhtine, A., Popik, V., and Tsourkas, A. (2013) Effect of ligand density, receptor density, and nanoparticle size on cell targeting Nanomedicine 9, 194-201
71. Shoffstall, A. J., Everhart, L. M., Varley, M. E., Soehnlen, E. S., Shick, A. M., Ustin, J. S., and Lavik, E. B. (2013) Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma Biomacromolecules 14, 2790-2797
72. Coller, B. S., Kutok, J. L., Scudder, L. E., Galanakis, D. K., West, S. M., Rudomen, G. S., and Springer, K. T. (1993) Studies of activated GPllb/llla receptors on the luminal surface of adherent platelets paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen J. Clin. Invest. 92, 2796-2806
73. Grannis, G. F. (1970) Plasma fibrinogen: determination, normal values, physiopathologic shifts, and fluctuations Clin Chem. 16, 486-494
74. Lord, S. T. (2007) Fibrinogen and fibrin: scaffold proteins in hemostasis Curr. Opin. Hematol. 14, 236-241
75. Blombäck, B., Carlsson, K., Fatah, K., Hessel, B., and Procyk, R. (1994) Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation Thromb. Res. 75, 521-538
76. Wolberg, A. S. (2007) Thrombin generation and fibrin clot structure Blood Rev. 21, 131-142
77. Brummel-Ziedins, K. E., Branda, R. F., Butenas, S., and Mann, K. G. (2009) Discordant fibrin formation in hemophilia J. Thromb. Haemost. 7, 825-832
78. Lord, S. T. (2011) Molecular mechanisms affecting fibrin structure and stability Arterioscler. Thromb. Vasc. Biol. 31, 494-499
79. Lorand, L., Parameswaran, K. N., and Murthy, S. N. (1998) A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa Proc. Natl. Acad. Sci. U. S. A. 95, 537-541
80. Laudano, A. P. and Doolittle, R. F. (1978) Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers Proc. Natl. Acad. Sci. U. S. A. 75, 3085-3089
81. Everse, S. J., Spraggon, G., Veerapandian, L., Riley, M., and Doolittle, R. F. (1998) Crystal structure of fragment double-D from human fibrin with two different bound ligands Biochemistry 37, 8637-8642
82. Soon, A. S., Lee, C. S., and Barker, T. H. (2011) Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide-PEG conjugates Biomaterials 32, 4406-4414
83. Stabenfeldt, S. E., Aboujamous, N. M., Soon, A. S., and Barker, T. H. (2011) A new direction for anticoagulants: Inhibiting fibrin assembly with PEGylated fibrin knob mimics Biotechnol. Bioeng. 108, 2424-33
84. Kolodziej, A. F., Nair, S. A., Graham, P., McMurry, T. J., Ladner, R. C., Wescott, C., Sexton, D. J., and Caravan, P. (2012) Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging Bioconjugate Chem. 23, 548-556
85. Kolodziej, A. F., Zhang, Z., Overoye-Chan, K., Jacques, V., and Caravan, P. (2014) Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents Methods Mol. Biol. 1088, 185-211
86. Vymazal, J., Spuentrup, E., Cardenas-Molina, G., Wiethoff, A. J., Hartmann, M. G., Caravan, P., and Parsons, E. C., Jr. (2009) Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility Invest. Radiol. 44, 697-704
87. Overoye-Chan, K., Koerner, S., Looby, R. J., Kolodziej, A. F., Zech, S. G., Deng, Q., Chasse, J. M., McMurry, T. J., and Caravan, P. (2008) EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus J. Am. Chem. Soc. 130, 6025-6039
88. Chan, L. W., Wang, X., Wei, H., Pozzo, L. D., White, N. J., and Pun, S. H. (2015) A Synthetic fibrin-crosslinking polymer for modulating clot properties and inducing hemostasis Sci. Transl. Med. 7, 277ra29
89. Brohi, K., Singh, J., Heron, M., and Coats, T. (2003) Acute traumatic coagulopathy J. Trauma 54, 1127-1130
90. Raza, I., Davenport, R., Rourke, C., Platton, S., Manson, J., Spoors, C., Khan, S., DeAth, H. D., Allard, S., and Hart, D. P. 2013, The incidence and magnitude of fibrinolytic activation in trauma patients J. Thromb. Haemost. 11, 307-314
91. Brown, A. C., Stabenfeldt, S. E., Ahn, B., Hannan, R. T., Dhada, K. S., Herman, E. S., Stefanelli, V., Guzzetta, N., Alexeev, A., and Lam, W. A. 2014, Ultrasoft microgels displaying emergent platelet-like behaviours Nat. Mater. 13, 1108-14
92. Osdoit, S. and Rosa, J. P. (2001) Fibrin clot retraction by human platelets correlates with α IIbβ3 integrin-dependent protein tyrosine dephosphorylation J. Biol. Chem. 276, 6703-6710
93. Teramura, Y., Okamura, Y., Takeoka, S., Tsuchiyama, H., Narumi, H., Kainoh, M., Handa, M., Ikeda, Y., and Tsuchida, E. (2003) Hemostatic effects of polymerized albumin particles bearing rGPIa/IIa in thrombocytopenic mice Biochem. Biophys. Res. Commun. 306, 256-260